Recent progress in LyP-1-based strategies for targeted imaging and therapy

Recent progress in LyP-1-based strategies for targeted imaging and therapy
复制标题

基于 LyP-1 的靶向成像和治疗策略的最新进展

DOI:
10.1080/10717544.2019.1587047
复制
发表时间:
2019-01
期刊:
影响因子:
6
通讯作者:
Zhao Jinhua
Zhao Jinhua
中科院分区:
医学2区
文献类型:
--
作者:
Song Ningning;Zhao Lingzhou;Zhu Meilin;Zhao Jinhua

文献摘要

参考文献

相似文献

摘要识别病变细胞或其微环境表达的标志物有助于区分病变细胞和正常组织。从这一理论衍生出来的策略可能是一种很有前途的成像和治疗疾病的方式。LYP-1是一种肿瘤归巢多肽,可以选择性地与其受体p32蛋白结合,在多种肿瘤相关细胞和动脉粥样硬化斑块巨噬细胞中过度表达。近几十年来,基于LYP-1的多种类型的成像探针和药物输送系统已被设计和开发用于诊断和治疗应用。本文首先介绍了LYP-1及其受体p32,以及它的归巢、内化和促凋亡特性。接下来,我们重点介绍基于LYP-1的策略在肿瘤、转移性病变和动脉粥样硬化斑块的诊断和治疗中的应用。最后,总结了基于LYP-1的生物结合物在临床翻译中的几个局限性。
Abstract The identification of markers expressed by pathological cells or their microenvironment would help to distinguish such cells from the normal tissues. The strategies derived from this theory can be a promising modality for imaging and treating diseases. LyP-1, a tumor homing peptide, can selectively bind to its receptor p32 protein overexpressed in various tumor-associated cells and atherosclerotic plaque macrophages. During recent decades, multiple types of LyP-1-based imaging probes and drug delivery systems have been designed and developed for diagnostic and therapeutic applications. This review first introduces LyP-1 and its receptor p32, as well as its homing, internalization and proapoptotic properties. Next, we highlight recent studies focusing on the applications of LyP-1-based strategies in the diagnosis and treatment of tumors, metastatic lesions, and atherosclerotic plaques. Finally, several limitations in the clinical translation of LyP-1-based bioconjugates are summarized.
DOI: 10.1080/07391102.2017.1313779
发表时间: 2018-04
影响因子: 4.4
作者:
S. Timur;Gozde Yalcin;Ö. Çevik;Cenk A Andac;R. N. Gürsoy
通讯作者: S. Timur;Gozde Yalcin;Ö. Çevik;Cenk A Andac;R. N. Gürsoy
DOI: 10.1073/pnas.90.8.3358
发表时间: 1993-04
影响因子: 11.1
作者:
H. Murakami;G. Blobel;D. Pain
通讯作者: H. Murakami;G. Blobel;D. Pain
DOI: 10.1158/0008-5472.can-07-6752
发表时间: 2008-09-01
期刊: Cancer research
影响因子: 11.2
作者:
Fogal V;Zhang L;Krajewski S;Ruoslahti E
通讯作者: Ruoslahti E
(64)用于动脉粥样硬化斑块的PET-CT成像的Cu标记的LYP-1树突中分析。
DOI: 10.1021/bc400347s
发表时间: 2014-02-19
影响因子: 4.7
作者:
Seo, Jai Woong;Baek, Hyounggee;Mahakian, Lisa M.;Kusunose, Jiro;Hamzah, Juliana;Ruoslahti, Erkki;Ferrara, Katherine W.
通讯作者: Ferrara, Katherine W.
DOI: 10.1126/scitranslmed.3003778
发表时间: 2012-08-15
影响因子: 17.1
作者:
Ren Y;Cheung HW;von Maltzhan G;Agrawal A;Cowley GS;Weir BA;Boehm JS;Tamayo P;Karst AM;Liu JF;Hirsch MS;Mesirov JP;Drapkin R;Root DE;Lo J;Fogal V;Ruoslahti E;Hahn WC;Bhatia SN
通讯作者: Bhatia SN